By Heidi Chen 30 Nov 2017
Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D
Trialtrove is the world’s most comprehensive source of pharmaceutical clinical trials intelligence from Citeline.
How it helps
Don’t waste time combing through onerous trials reports to get the information you need. Trialtrove analysts do the information gathering for you.
How it works
Trialtrove uses over 40,000 sources to bring you the most comprehensive trial intelligence imaginable.
We extract the protocol details that matter, including objectives, endpoints, and inclusion/exclusion criteria. We also add industry-relevant search terms such as our proprietary patient segments, trial outcomes and biomarker tags, so that you can quickly filter to get to the up-to-date information you need.
Analyst reviewed data and enriched content
Comprehensive data on design details, outcomes, timelines, results, and more
Proprietary prescriber data to view disease and country-level treatment regimens
Unlimited support for your research from experienced industry analysts
Instantly and easily generate custom tables and charts of key trial attributes
Create, monitor, and track updates on and changes to your custom searches
By Doro Shin 09 Aug 2017
Breast cancer trials are making the most use of personalized medicine developments in trials, according to data gathered by Trialtrove.
By Laura Runkel 19 Jun 2017
Biosimilars for autoimmune drugs, including humira, remicade, etanercept, rituximab and others, have been in clinical development for several years.
By Doro Shin 31 May 2017
One Size No Longer Fits All comes to you from In Vivo, part of the Informa Pharma Intelligence suite of tools. Leveraging a unique array of news, data, analysis, and consulting products and services.
Topic Personalized Medicine
By Christine Blazynski PhD 30 May 2017
Company pipeline depictions are snapshots that illustrate, at that point in time, where a therapeutic candidate sits in terms of development stage for a specific therapy area or disease.
Medtrack, Trialtrove, Strategic Transactions
By Patricia Giglio 12 May 2017
Experts from Informa’s Medtrack, Trialtrove and Strategic Transactions teams presented a panel discussion at the recent T3 Conference in Orlando, Florida.
By Ethan Hebert 19 Apr 2017
Currently there are no approved pharmacological treatments for non-alcoholic fatty liver disease (NAFLD), including the subtype non-alcoholic steatohepatitis (NASH).
Topic Clinical trials
Pharmaprojects, Sitetrove, Trialtrove
19 Apr 2017
The R&D Annual Review webinar is happening soon. Take a look back at pharma R&D in 2016 and look ahead to the remainder of the year to get expert insight from the senior experts at Pharma Intelligence during this free webinar.
By Robin Custeau 01 Apr 2017
Given the current limited options and future demand for renal anemia treatment, pharmaceutical companies will have an opportunity to capitalize on this market.
Laura specializes in
+32 year(s) experience
Judy specializes in
+30 year(s) experience
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: